De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).

MLA

de Wild, Sabine R., et al. “De-Escalation of Axillary Treatment in the Event of a Positive Sentinel Lymph Node Biopsy in CT1–2 N0 Breast Cancer Treated with Mastectomy: Nationwide Registry Study (BOOG 2013-07).” British Journal of Surgery, vol. 111, no. 4, Apr. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1093/bjs/znae077.

APA

de Wild, S. R., van Roozendaal, L. M., de Wilt, J. H. W., van Dalen, T., van der Hage, J. A., van Duijnhoven, F. H., Simons, J. M., Schipper, R.-J., de Munck, L., van Kuijk, S. M. J., Boersma, L. J., Linn, S. C., Lobbes, M. B. I., Poortmans, P. M. P., Tjan-Heijnen, V. C. G., van de Vijver, K. K. B. T., de Vries, J., Westenberg, A. H., Strobbe, L. J. A., & Smidt, M. L. (2024). De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07). British Journal of Surgery, 111(4), 1–10. https://doi.org/10.1093/bjs/znae077

Chicago

de Wild, Sabine R, Lori M van Roozendaal, Johannes H W de Wilt, Thijs van Dalen, Jos A van der Hage, Frederieke H van Duijnhoven, Janine M Simons, et al. 2024. “De-Escalation of Axillary Treatment in the Event of a Positive Sentinel Lymph Node Biopsy in CT1–2 N0 Breast Cancer Treated with Mastectomy: Nationwide Registry Study (BOOG 2013-07).” British Journal of Surgery 111 (4): 1–10. doi:10.1093/bjs/znae077.